Latest / The BioHub - by Avetix
Episode 21 - Chris Haqq - CMO Elicio Therapeutics
Welcome back to another episode of The BioHub!
Today, we’re thrilled to have Dr. Chris Haqq, Chief Medical Officer and Head of Research & Development at Elicio Therapeutics, join us.
Chris is an expert in immuno-oncology with over 20 years of experience in the biotech industry. He has a remarkable track record in leading innovative therapies from concept to clinical stages, including his pivotal role in developing groundbreaking T cell therapies at Atara Biotherapeutics.
In this episode, we’ll explore Elicio’s unique approach to cancer immunotherapy, Chris’s insights on the current biotech…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.